| Translated title of the contribution | Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors. |
|---|---|
| Original language | Undefined/Unknown |
| Pages (from-to) | 1491-1498 |
| Number of pages | 8 |
| Journal | Journal of Clinical Oncology |
| Volume | 24 |
| Issue number | 10 |
| Publication status | Published - 2006 |
Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors.
L.V. Beerepoot, S.A Radema, E.O. Witteveen, T. Thomas, C. Wheeler, S. Kempin, E.E. Voest
Research output: Contribution to journal › Article › Academic › peer-review